SCHEMBL20133811

SCHEMBL20133811

C=C(C)c1cc(NC2CCN(c3ccccc3)CC2)c(C)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.41
RPTOR Q8N122 4/20 0.41
MLST8 Q9BVC4 4/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.39
JAK1 P23458 1/20 0.38
MAPT P10636 1/20 0.38
EHMT2 Q96KQ7 1/20 0.37
RPS6KB1 P23443 1/20 0.37
CNR1 P21554 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
EPHX2 P34913 1/20 0.36
HDAC1 Q13547 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
NPY5R Q15761 1/20 0.35
MBTD1 Q05BQ5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141082 0.86 MTOR (0.45) MTORRPTORMLST8MEN1KMT2A
SCHEMBL20141600 0.83 MAPT (0.49) MTORRPTORMLST8MEN1KMT2A
SCHEMBL20133698 0.77 ALDH1A1 (0.50) MEN1KMT2AALDH1A1TSHRMAPT
SCHEMBL20133837 0.75 MTNR1A (0.49) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL21360385 0.74 MTOR (0.72) MTORRPTORMLST8MEN1KMT2A
SCHEMBL21360289 0.74 MTOR (0.60) MTORRPTORMLST8MEN1KMT2A
SCHEMBL20149902 0.74 MTOR (0.72) MTORRPTORMLST8MEN1KMT2A
SCHEMBL20133680 0.74 NOTUM (0.51) MTORRPTORMLST8JAK1RPS6KB1
SCHEMBL20149877 0.73 MTOR (0.53) MTORRPTORMLST8MEN1KMT2A
SCHEMBL20133703 0.73 MTOR (0.49) MTORRPTORMLST8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.